Evidence map›Paper›PMID 36480716›Full record

ArticleAlimentary pharmacology & therapeutics2023

Letter: PCSK9 inhibitor for liver transplant patients during the post-statin era?

Jiamei Wang, Jia Wu, Zhiqing He, Haiguang Xin

Open access · bronzeAbstract readLetterComment
PubMed Publisher
In one paragraph

Article in Alimentary pharmacology & therapeutics, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.2field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 1 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 2 countries.

Jiamei WangDepartment of Cardiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.
Jia WuDepartment of Health Management Center, Shanghai Changzheng Hospital, Naval Medical University, Shanghai, China.
Zhiqing HeDepartment of Cardiology, Second Affiliated Hospital of Naval Medical University, Shanghai, China.ORCID 0000-0001-8363-1286
Haiguang XinDepartment of Infectious Diseases, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Shanghai Changzheng Hospital · CNShanghai Jiao Tong University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Hydroxymethylglutaryl-CoA Reductase InhibitorsLiver TransplantationAntiviral AgentsHumansProprotein Convertase 9Antiviral AgentsHydroxymethylglutaryl-CoA Reductase InhibitorsPCSK9 protein, humanProprotein Convertase 9

Identifiers

PMID36480716
OpenAlexW4311575701

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.